Beyond Inflammation: Blocking COX-2 May Provide Therapy for Multiple Diseases

UPSTREAM, DOWNSTREAM: Biochemical activity upstream of cyclooxygenase is better understood than reactions downstream of the enzyme. Cancer, Alzheimer's disease, and stroke represent disparate destinations. But the pathogenic road leading to each passes through one enzyme: cyclooxygenase-2 (COX-2). Because of that biochemical junction, a class of compounds called COX-2 inhibitors, originally designed as anti-inflammatory agents against arthritis, may have broader utility. The relationship betwe

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share


UPSTREAM, DOWNSTREAM: Biochemical activity upstream of cyclooxygenase is better understood than reactions downstream of the enzyme.
Cancer, Alzheimer's disease, and stroke represent disparate destinations. But the pathogenic road leading to each passes through one enzyme: cyclooxygenase-2 (COX-2). Because of that biochemical junction, a class of compounds called COX-2 inhibitors, originally designed as anti-inflammatory agents against arthritis, may have broader utility.

The relationship between anti-inflammatory drugs and other diseases appeared epidemiologically before COX-2 inhibitors were tested. When scientists at pharmaceutical companies tested their own COX-2 inhibitors as anti-inflammatory agents in clinical trials, those epidemiological links became stronger. Now, both companies are testing their compounds for efficacy against conditions other than arthritis. And scientists are now examining how one mechanism can affect many diseases. "Undoubtedly, there are many diseases that will share common pathways, be it inflammation, carcinogenesis, or neurodegenerative processes," notes Andrew J. Dannenberg, director of the Strang-Cornell Gastrointestinal Cancer Prevention ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Paul Smaglik

    This person does not yet have a bio.

Published In

Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
iStock: Ifongdesign

The Advent of Automated and AI-Driven Benchwork

sampled
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

dispensette-s-group

BRAND® Dispensette® S Bottle Top Dispensers for Precise and Safe Reagent Dispensing

Sapio Sciences

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

DeNovix Logo

New DeNovix Helium Nano Volume Spectrophotometer

Olink Logo

Olink® Reveal: Accessible NGS-based proteomics for every lab

Olink logo